Yilmaz O - Search Results

1

New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors.

Vilaça J, Yilmaz O, Torres T. Vilaça J, et al. Among authors: yilmaz o. Pharmaceutics. 2024 Jul 6;16(7):908. doi: 10.3390/pharmaceutics16070908. Pharmaceutics. 2024. PMID: 39065604 Free PMC article. Review.

2

New and emerging oral therapies for psoriasis.

Yilmaz O, Pinto JP, Torres T. Yilmaz O, et al. Drugs Context. 2024 Aug 1;13:2024-5-6. doi: 10.7573/dic.2024-5-6. eCollection 2024. Drugs Context. 2024. PMID: 39131603 Free PMC article. Review.

3

Extended Half-life Antibodies: A Narrative Review of a New Approach in the Management of Atopic Dermatitis.

Yilmaz O, Torres T. Yilmaz O, et al. Dermatol Ther (Heidelb). 2024 Sep;14(9):2393-2406. doi: 10.1007/s13555-024-01253-6. Epub 2024 Aug 15. Dermatol Ther (Heidelb). 2024. PMID: 39147994 Free PMC article. Review.

4

IL-13 inhibition in the treatment of atopic dermatitis - new and emerging biologic agents.

Teixeira C, Yilmaz O, Bernardo D, Torres T. Teixeira C, et al. Among authors: yilmaz o. J Int Med Res. 2024 Nov;52(11):3000605241286832. doi: 10.1177/03000605241286832. J Int Med Res. 2024. PMID: 39558725 Free PMC article. Review.

5

A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab.

Abdelhalim A, Yilmaz O, Elshaikh Berair M, Torres T. Abdelhalim A, et al. Among authors: yilmaz o. Dermatol Ther (Heidelb). 2024 Dec;14(12):3197-3210. doi: 10.1007/s13555-024-01308-8. Epub 2024 Nov 20. Dermatol Ther (Heidelb). 2024. PMID: 39565527 Free PMC article. Review.

6

Effectiveness and tolerance of tralokinumab after failure with dupilumab and baricitinib in a patient with atopic dermatitis.

Freitas E, Yilmaz O, Torres T. Freitas E, et al. Among authors: yilmaz o. Eur J Dermatol. 2024 Oct 1;34(5):551-553. doi: 10.1684/ejd.2024.4773. Eur J Dermatol. 2024. PMID: 39589047 No abstract available.

7

Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa.

Pinto Salgueiro G, Yilmaz O, Nogueira M, Torres T. Pinto Salgueiro G, et al. Among authors: yilmaz o. BioDrugs. 2025 Jan;39(1):53-74. doi: 10.1007/s40259-024-00687-w. Epub 2024 Nov 28. BioDrugs. 2025. PMID: 39604776 Free PMC article. Review.

8

Oral roflumilast for psoriasis: a real-world 24-week prospective cohort study.

Lé AM, Yilmaz O, Luz M, Torres T. Lé AM, et al. Among authors: yilmaz o. J Dermatolog Treat. 2025 Dec;36(1):2464107. doi: 10.1080/09546634.2025.2464107. Epub 2025 Feb 11. J Dermatolog Treat. 2025. PMID: 39933751 Free article.

9

Topical delgocitinib for the treatment of chronic hand eczema.

Abdelhalim A, Yilmaz O, Elshaikh Berair M, Torres T. Abdelhalim A, et al. Among authors: yilmaz o. J Dermatolog Treat. 2025 Dec;36(1):2479126. doi: 10.1080/09546634.2025.2479126. Epub 2025 Mar 17. J Dermatolog Treat. 2025. PMID: 40096745 Free article. Review.

10

Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicentre retrospective study.

Torres T, Sood S, Yilmaz O, Vender RB, Prajapati VH, Puig L, Megna M, Marzano AV, Gisondi P, Carrascosa JM, Dauden E, Llamas-Velasco M, Balato A, Leal BG, Prignano F, Bellinato F, Silvi G, Di Brizzi EV, Potestio L, Sechi A, Carrera CG, López-Ferrer A, Del-Alcazar E, Mufti A, Maul LV, Piaserico S, Maul JT, Yeung J. Torres T, et al. Among authors: yilmaz o. Clin Exp Dermatol. 2025 Nov 25;50(12):2496-2497. doi: 10.1093/ced/llaf342. Clin Exp Dermatol. 2025. PMID: 40726424 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,756 results

Search Page

Filters